⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PTHS News
Pelthos Therapeutics Inc.
Form 8-K
sec.gov
PTHS
Pelthos Therapeutics Announces Second Quarter 2026 Financial Results
globenewswire.com
PTHS
Form 8-K
sec.gov
PTHS
Pelthos Therapeutics to Report Second Quarter 2026 Financial Results on August 13, 2026
globenewswire.com
PTHS
Pelthos Therapeutics Announces 2026 Annual Meeting of Stockholders
globenewswire.com
PTHS
Pelthos Therapeutics Added to Russell 3000E™ Growth Benchmark, Russell Microcap® and Russell Microcap® Growth Benchmark Indexes
globenewswire.com
PTHS
Palvella Therapeutics Appoints Accomplished Rare Disease Biotech Executive and Commercial Leader Matt Pauls, J.D., M.B.A., to Board of Directors
globenewswire.com
SVRA
SLNO
INSM
PVLA
PTHS
Form 8-K
sec.gov
PTHS
Pelthos Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference
globenewswire.com
PTHS
Form 8-K
sec.gov
PTHS